NM_144573.4:c.379C>T
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BS2
The NM_144573.4(NEXN):c.379C>T(p.Arg127Cys) variant causes a missense change. The variant allele was found at a frequency of 0.0000211 in 1,613,586 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R127H) has been classified as Likely benign.
Frequency
Consequence
NM_144573.4 missense
Scores
Clinical Significance
Conservation
Publications
- dilated cardiomyopathyInheritance: AD Classification: MODERATE Submitted by: ClinGen
- familial isolated dilated cardiomyopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- dilated cardiomyopathy 1CCInheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
- hypertrophic cardiomyopathyInheritance: AD Classification: LIMITED Submitted by: ClinGen
- hypertrophic cardiomyopathy 20Inheritance: AD Classification: LIMITED Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -4 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000264 AC: 4AN: 151780Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000321 AC: 8AN: 249500 AF XY: 0.0000296 show subpopulations
GnomAD4 exome AF: 0.0000205 AC: 30AN: 1461806Hom.: 0 Cov.: 32 AF XY: 0.0000234 AC XY: 17AN XY: 727218 show subpopulations
GnomAD4 genome AF: 0.0000264 AC: 4AN: 151780Hom.: 0 Cov.: 32 AF XY: 0.0000270 AC XY: 2AN XY: 74080 show subpopulations
ClinVar
Submissions by phenotype
not provided Uncertain:2
Has not been previously published as pathogenic or benign to our knowledge; Reported in ClinVar as a variant of uncertain significance (ClinVar Variant ID# 229058; Landrum et al., 2016); In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect -
- -
Dilated cardiomyopathy 1CC;C3151267:Hypertrophic cardiomyopathy 20 Uncertain:2
- -
This sequence change replaces arginine with cysteine at codon 127 of the NEXN protein (p.Arg127Cys). The arginine residue is moderately conserved and there is a large physicochemical difference between arginine and cysteine. This variant is present in population databases (rs771113424, ExAC 0.01%). This variant has not been reported in the literature in individuals affected with NEXN-related conditions. ClinVar contains an entry for this variant (Variation ID: 229058). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C15"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
not specified Uncertain:1
The p.Arg127Cys variant in NEXN has not been previously reported in individuals with cardiomyopathy, but has been identified in 2/16510 South Asian chromosomes and 2/66726 European chromosomes by the Exome Aggregation Consortium (ExAC, http ://exac.broadinstitute.org). Computational prediction tools and conservation ana lysis suggest that this variant may impact the protein, though this information is not predictive enough to determine pathogenicity. In summary, the clinical si gnificance of the p.Arg127Cys variant is uncertain. -
Cardiovascular phenotype Uncertain:1
The p.R127C variant (also known as c.379C>T), located in coding exon 4 of the NEXN gene, results from a C to T substitution at nucleotide position 379. The arginine at codon 127 is replaced by cysteine, an amino acid with highly dissimilar properties. This amino acid position is conserved. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at